Literature DB >> 8070141

Clusterin: modulation of complement function.

J Tschopp1, L E French.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8070141      PMCID： PMC1550357          DOI： 10.1111/j.1365-2249.1994.tb06256.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  23 in total

Review 1.  Heymann nephritis: mechanisms of renal injury.

Authors:  D J Salant; R J Quigg; A V Cybulsky
Journal:  Kidney Int       Date:  1989-04       Impact factor: 10.612

2.  Molecular structure and functional characterization of a human complement cytolysis inhibitor found in blood and seminal plasma: identity to sulfated glycoprotein 2, a constituent of rat testis fluid.

Authors:  D E Jenne; J Tschopp
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

3.  Changes in brain gene expression shared by scrapie and Alzheimer disease.

Authors:  J R Duguid; C W Bohmont; N G Liu; W W Tourtellotte
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

Review 4.  Clusterin: the intriguing guises of a widely expressed glycoprotein.

Authors:  D E Jenne; J Tschopp
Journal:  Trends Biochem Sci       Date:  1992-04       Impact factor: 13.807

5.  Localization of clusterin in the epimembranous deposits of passive Heymann nephritis.

Authors:  A A Eddy; I B Fritz
Journal:  Kidney Int       Date:  1991-02       Impact factor: 10.612

6.  Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9.

Authors:  J Tschopp; A Chonn; S Hertig; L E French
Journal:  J Immunol       Date:  1993-08-15       Impact factor: 5.422

Review 7.  Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease.

Authors:  P L McGeer; J Rogers
Journal:  Neurology       Date:  1992-02       Impact factor: 9.910

8.  Clusterin (complement lysis inhibitor) forms a high density lipoprotein complex with apolipoprotein A-I in human plasma.

Authors:  D E Jenne; B Lowin; M C Peitsch; A Böttcher; G Schmitz; J Tschopp
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

9.  Apolipoprotein J: structure and tissue distribution.

Authors:  H V de Silva; J A Harmony; W D Stuart; C M Gil; J Robbins
Journal:  Biochemistry       Date:  1990-06-05       Impact factor: 3.162

10.  Molecular cloning and characterization of the novel, human complement-associated protein, SP-40,40: a link between the complement and reproductive systems.

Authors:  L Kirszbaum; J A Sharpe; B Murphy; A J d'Apice; B Classon; P Hudson; I D Walker
Journal:  EMBO J       Date:  1989-03       Impact factor: 11.598
View more
  15 in total

Review 1.  Complement activation, regulation, and molecular basis for complement-related diseases.

Authors:  Goran Bajic; Søren E Degn; Steffen Thiel; Gregers R Andersen
Journal:  EMBO J       Date:  2015-10-21       Impact factor: 11.598

2.  Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment.

Authors:  Madhav Thambisetty; Yang An; Anna Kinsey; Deepthi Koka; Muzamil Saleem; Andreas Güntert; Michael Kraut; Luigi Ferrucci; Christos Davatzikos; Simon Lovestone; Susan M Resnick
Journal:  Neuroimage       Date:  2011-07-28       Impact factor: 6.556

3.  Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.

Authors:  M Navab; S Hama-Levy; B J Van Lenten; G C Fonarow; C J Cardinez; L W Castellani; M L Brennan; A J Lusis; A M Fogelman; B N La Du
Journal:  J Clin Invest       Date:  1997-04-15       Impact factor: 14.808

4.  Functional and structural properties of lipid-associated apolipoprotein J (clusterin).

Authors:  M Calero; T Tokuda; A Rostagno; A Kumar; B Zlokovic; B Frangione; J Ghiso
Journal:  Biochem J       Date:  1999-12-01       Impact factor: 3.857

5.  Low clusterin levels in high-density lipoprotein associate with insulin resistance, obesity, and dyslipoproteinemia.

Authors:  Andrew N Hoofnagle; Mingyuan Wu; Albina K Gosmanova; Jessica O Becker; Ellen M Wijsman; John D Brunzell; Steven E Kahn; Robert H Knopp; Timothy J Lyons; Jay W Heinecke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-09-16       Impact factor: 8.311

6.  Clusterin and complement activation in exfoliation glaucoma.

Authors:  Ivo Doudevski; Agueda Rostagno; Mary Cowman; Jeffrey Liebmann; Robert Ritch; Jorge Ghiso
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-17       Impact factor: 4.799

7.  Clusterin and LRP2 are critical components of the hypothalamic feeding regulatory pathway.

Authors:  So Young Gil; Byung-Soo Youn; Kyunghee Byun; Hu Huang; Churl Namkoong; Pil-Geum Jang; Joo-Yong Lee; Young-Hwan Jo; Gil Myoung Kang; Hyun-Kyong Kim; Mi-Seon Shin; Claus U Pietrzik; Bonghee Lee; Young-Bum Kim; Min-Seon Kim
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

8.  Alzheimer's risk variants in the clusterin gene are associated with alternative splicing.

Authors:  M Szymanski; R Wang; S S Bassett; D Avramopoulos
Journal:  Transl Psychiatry       Date:  2011       Impact factor: 6.222

Review 9.  Evolution and Function of Thioester-Containing Proteins and the Complement System in the Innate Immune Response.

Authors:  Upasana Shokal; Ioannis Eleftherianos
Journal:  Front Immunol       Date:  2017-06-29       Impact factor: 7.561

10.  Mass spectrometry assays of plasma biomarkers to predict radiographic progression of knee osteoarthritis.

Authors:  Susan Y Ritter; Jamie Collins; Bryan Krastins; David Sarracino; Mary Lopez; Elena Losina; Antonios O Aliprantis
Journal:  Arthritis Res Ther       Date:  2014-10-07       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.